Suppr超能文献

别嘌醇诱导的鼠肝匀浆中 δ-氨基酮戊酸脱水酶活性抑制的动力学。

Kinetics of alloxan-induced inhibition on δ-aminolevulinate dehydratase activity in mouse liver homogenates.

机构信息

Departamento de Química, Centro de Ciências Naturais e Exatas, Universidade Federal de Santa Maria, UFSM, 97105-900, Santa Maria, Rio Grande do Sul, Brazil.

出版信息

Appl Biochem Biotechnol. 2012 Feb;166(4):1047-56. doi: 10.1007/s12010-011-9492-8. Epub 2011 Dec 30.

Abstract

This study evaluated the effects of alloxan on the kinetics properties of the δ-aminolevulinate dehydratase (δ-ALA-D) using mouse liver homogenates. δ-ALA-D is an important sulfhydryl enzyme that catalyses the second step in heme biosynthesis and is commonly diminished in experimental and human diabetes. Despite the known effects of alloxan in models of experimental diabetes, there are no data in the literature demonstrating the effects of alloxan on the kinetics properties of the δ-ALA-D. The results showed that alloxan (1.25-20 μM) caused a concentration-dependent inhibition of hepatic δ-ALA-D activity. The inhibition constant (K(i)) for alloxan-induced inhibition on δ-ALA-D was 3.64 μM. The alloxan (5 μM) caused a decrease in V(max) (65.8%) and in K(m) (53.1%), which is suggestive of an uncompetitive inhibition of enzyme. In addition, dithiothreitol (700 and 1,000 μM) completely prevented the δ-ALA-D activity inhibition induced by 10 and 20 μM alloxan. Similar protection was obtained in the presence of 2,000 μM glutathione. Therefore, this work showed that the inhibition of hepatic δ-ALA-D activity can be obtained in vitro at low micromolar levels of alloxan, and can also be prevented by reducing agents. Moreover, these results may help to understand the abnormalities in heme pathway found in models of experimental diabetes in vivo.

摘要

本研究采用小鼠肝匀浆评价了别嘌呤醇对δ-氨基酮戊酸脱水酶(δ-ALA-D)动力学特性的影响。δ-ALA-D 是一种重要的巯基酶,催化血红素生物合成的第二步,在实验性和人类糖尿病中通常减少。尽管别嘌呤醇在实验性糖尿病模型中有已知的作用,但文献中没有数据表明别嘌呤醇对 δ-ALA-D 动力学特性的影响。结果表明,别嘌呤醇(1.25-20 μM)对肝 δ-ALA-D 活性有浓度依赖性抑制作用。别嘌呤醇诱导的 δ-ALA-D 抑制的抑制常数(K(i))为 3.64 μM。别嘌呤醇(5 μM)导致 V(max)(65.8%)和 K(m)(53.1%)降低,提示酶呈非竞争性抑制。此外,二硫苏糖醇(700 和 1000 μM)完全阻止了 10 和 20 μM 别嘌呤醇诱导的 δ-ALA-D 活性抑制。在 2000 μM 谷胱甘肽存在下也获得了类似的保护。因此,本工作表明,在低微摩尔水平的别嘌呤醇下,可以在体外获得肝 δ-ALA-D 活性的抑制,并且还原剂也可以预防这种抑制。此外,这些结果可能有助于理解体内实验性糖尿病模型中血红素途径的异常。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验